ENTITY
Shenzhen New Industries Biomedical Engineering-A

Shenzhen New Industries Biomedical Engineering-A (300832 CH)

27
Analysis
Health CareChina
Shenzhen New Industries Biomedical Engineering Co., Ltd. operates as a biomedical company. The Company researches, develops, produces, and sells clinical laboratory instrument and vitro diagnostic reagent. Shenzhen New Industries Biomedical Engineering also offers related technical service.
more

Quiddity CSI 300/​​500 Jun 24 Rebalance: 92% Hit Rate; US$3.7bn One-Way Flows

The Inclusion/Exclusion events can be expected to take place at the close of trading on Friday 14th June 2024. We expect certain inflow names to...

Share

CSI300 Index Rebalance Preview: Potential Adds Outperforming Despite ETF Inflows

The adds have outperformed the deleted by over 10% in the last month. Coming up to the end of the review period, there could be further positioning.

Logo
927 Views
Share
13 Jun 2024 07:27

CSI300/CSI500 Index Rebalance: Big Flows and US$5bn Round-Trip Trade

The CSI300/CSI500 indices rebalance at the close tomorrow. Since announcement, the inclusions to the CSI300 index have outperformed the deletes by...

Logo
559 Views
Share
06 May 2024 06:10

CSI300 Index Rebalance Preview: Bounce in the Potential Deletes Could Be Short Lived

There could be 11 changes for the CSI300 in June with multiple days of ADV to trade on most names. The potential deletes have bounced recently but...

Logo
636 Views
Share
09 Apr 2024 15:57

Quiddity Leaderboard CSI 300/​​500 Jun 24: SHORTs Down 11% Vs Index Since Mid-Feb; Change the Hedge

I estimate one-way flows of US$1.45bn for the CSI 300 rebalance and US$2.35bn for the CSI 500 rebalance in June 2024. These estimates could still...

Share
x